
Vivanta Industries Board Meeting on July 24, 2026
Vivanta Industries Ltd has announced a Board of Directors meeting scheduled for July 24, 2026. The meeting will primarily focus on considering and approving the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026, along with the Limited Review Report. Additionally, the board will authorize signatories for financial statements for the year ended March 31, 2026, take note of duplicate share certificates issued, a business collaboration agreement with Qness Pharmaceuticals, the Corporate Governance Report, and the E-Form DPT-3 Return of Deposits for the quarter. The trading window for designated persons remains closed until 48 hours after the financial results declaration.
Key Highlights
- Board meeting scheduled for July 24, 2026.
- To approve Unaudited Standalone and Consolidated Financial Results for Q1 FY27.
- Will discuss business collaboration with Qness Pharmaceuticals.
- Corporate Governance Report and E-Form DPT-3 to be noted.
- Trading window remains closed until results announcement.
Price Impact
More from VIVANTA